Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin for Hyperphosphatemia and Lp(a) in ESRD
NCT06406140Phase 3Enrolling by invitation
- Sponsor
- Al-Azhar University
- Start
- Mar 2024
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of niacin in hyperphosphatemia, Elevated Lipoprotein(a) (Lp(a)), sponsored by Al-Azhar University. Started Mar 2024; status: enrolling by invitation.
02
Drugs
niacin
03
Conditions
hyperphosphatemiaElevated Lipoprotein(a) (Lp(a))
Beyond the preview
Go deeper on NCT06406140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06406140.